The Fort Worth Press - Entero Regains Nasdaq Compliance With Grid AI Acquisition

USD -
AED 3.672499
AFN 66.073567
ALL 82.870557
AMD 381.4977
ANG 1.790055
AOA 916.999821
ARS 1441.4753
AUD 1.505741
AWG 1.80125
AZN 1.733153
BAM 1.678705
BBD 2.013364
BDT 122.282772
BGN 1.67875
BHD 0.376983
BIF 2953.569114
BMD 1
BND 1.294944
BOB 6.907739
BRL 5.342698
BSD 0.999601
BTN 89.876145
BWP 13.280747
BYN 2.873917
BYR 19600
BZD 2.010437
CAD 1.38815
CDF 2229.999833
CHF 0.803965
CLF 0.023435
CLP 919.350363
CNY 7.07165
CNH 7.06997
COP 3805.96
CRC 488.298936
CUC 1
CUP 26.5
CVE 94.627762
CZK 20.788021
DJF 178.006472
DKK 6.413095
DOP 63.979263
DZD 129.960902
EGP 47.561498
ERN 15
ETB 155.051714
EUR 0.858701
FJD 2.26196
FKP 0.748861
GBP 0.749545
GEL 2.707732
GGP 0.748861
GHS 11.370991
GIP 0.748861
GMD 73.000349
GNF 8684.831581
GTQ 7.657084
GYD 209.137648
HKD 7.785415
HNL 26.328145
HRK 6.4661
HTG 130.859652
HUF 327.985502
IDR 16684.25
ILS 3.22337
IMP 0.748861
INR 89.94655
IQD 1309.540669
IRR 42124.999963
ISK 127.770338
JEP 0.748861
JMD 159.999657
JOD 0.708958
JPY 155.330495
KES 129.303563
KGS 87.450404
KHR 4002.334624
KMF 421.999991
KPW 899.993191
KRW 1472.349808
KWD 0.30692
KYD 0.833083
KZT 505.531856
LAK 21676.809119
LBP 89516.767233
LKR 308.334728
LRD 175.938682
LSL 16.941802
LTL 2.95274
LVL 0.60489
LYD 5.434032
MAD 9.231238
MDL 17.00842
MGA 4458.959547
MKD 52.906919
MMK 2099.939583
MNT 3546.502114
MOP 8.016033
MRU 39.863012
MUR 46.070177
MVR 15.409874
MWK 1733.372244
MXN 18.18685
MYR 4.110984
MZN 63.900796
NAD 16.941802
NGN 1450.629832
NIO 36.787647
NOK 10.098385
NPR 143.802277
NZD 1.730535
OMR 0.384493
PAB 0.999682
PEN 3.360156
PGK 4.24115
PHP 58.974994
PKR 280.247111
PLN 3.633165
PYG 6875.152888
QAR 3.643659
RON 4.373102
RSD 100.813002
RUB 77.272376
RWF 1454.419048
SAR 3.753229
SBD 8.223823
SCR 13.511902
SDG 601.503673
SEK 9.407755
SGD 1.29544
SHP 0.750259
SLE 23.000032
SLL 20969.498139
SOS 570.266164
SRD 38.629019
STD 20697.981008
STN 21.02887
SVC 8.745763
SYP 11058.244165
SZL 16.928669
THB 31.8565
TJS 9.171638
TMT 3.5
TND 2.932369
TOP 2.40776
TRY 42.508699
TTD 6.776446
TWD 31.272004
TZS 2434.999856
UAH 41.959408
UGX 3536.283383
UYU 39.096531
UZS 11958.989413
VES 248.585897
VND 26360
VUV 122.070109
WST 2.790151
XAF 563.019389
XAG 0.017073
XAU 0.000236
XCD 2.70255
XCG 1.801608
XDR 0.70002
XOF 562.932418
XPF 102.347136
YER 238.398782
ZAR 16.93566
ZMK 9001.203093
ZMW 23.111058
ZWL 321.999592
  • RYCEF

    0.0500

    14.7

    +0.34%

  • RBGPF

    0.0000

    78.35

    0%

  • CMSC

    -0.0890

    23.391

    -0.38%

  • BTI

    -0.9700

    57.07

    -1.7%

  • GSK

    -0.4140

    48.156

    -0.86%

  • VOD

    -0.1730

    12.46

    -1.39%

  • AZN

    0.3900

    90.42

    +0.43%

  • RIO

    -0.2800

    73.45

    -0.38%

  • BP

    -0.7800

    36.45

    -2.14%

  • NGG

    -0.3050

    75.605

    -0.4%

  • SCS

    -0.0800

    16.15

    -0.5%

  • RELX

    -0.1000

    40.44

    -0.25%

  • BCC

    -0.1800

    74.08

    -0.24%

  • JRI

    0.0500

    13.8

    +0.36%

  • BCE

    0.2530

    23.473

    +1.08%

  • CMSD

    -0.0350

    23.285

    -0.15%

Entero Regains Nasdaq Compliance With Grid AI Acquisition
Entero Regains Nasdaq Compliance With Grid AI Acquisition

Entero Regains Nasdaq Compliance With Grid AI Acquisition

BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI Corp. ("Grid AI"), it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule").

Text size:

Entero's publicly‑listed platform now sits at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition of Grid AI, now operating as a wholly‑owned subsidiary of Entero, enables the Company to participate in one of the most significant secular growth arenas of the coming decade: hyperscale data centers, grid‑edge orchestration, and AI‑driven infrastructure optimization.

Forward‑Looking Statements
This press release contains forward‑looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the strategic benefits of the acquisition, the integration of Grid AI, the ability to maintain compliance with Nasdaq's listing criteria in connection with the Grid AI acquisition and otherwise, the ability to obtain shareholder approval of the common stock underlying the preferred stock issued in the Grid AI acquisition, expected future operating results, market opportunities, and the Company's growth strategy. Actual results may differ materially due to risks and uncertainties. The Company undertakes no obligation to update forward‑looking statements except as required by law.

About Entero Therapeutics, Inc.
Entero Therapeutics (NASDAQ:ENTO) is a publicly listed company. The Company's programs address significant unmet needs in gastrointestinal (GI) health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. Following the acquisition of Grid AI, the Company is continuing these prior operations and is also repositioning into the infrastructure, AI and data‑centre orchestration space. Entero operates Grid AI as a wholly‑owned subsidiary and intends to leverage its public‑market listing and corporate resources to scale the new venture.

About Grid AI
Grid AI is an AI‑driven, grid‑edge software and device orchestration platform enabling business, utility, and hyperscaler customers to forecast, optimize, and dispatch flexible demand, DERs and compute assets. The platform supports major ML frameworks, offers rapid scale across cloud GPU/CPU infrastructure, and is designed to deliver SaaS‑like recurring revenue.

Investor & Media Contacts:
Entero Investor Relations
[email protected]

SOURCE: Entero Therapeutics, Inc.



View the original press release on ACCESS Newswire

L.Holland--TFWP